Pnina Fishman
7PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 15, 2026
The anti-obesity effect of namodenoson, an A3 adenosine receptor agonist.Pnina Fishman, Inbal Itzhak, Rifaat Safadi
|Jan 27, 2024
Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT-1).K A Papp, S Beyska-Rizova, M L Gantcheva
|Feb 13, 2023
Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects.Pnina Fishman, Salomon M Stemmer, Avital Bareket-Samish
|Jun 22, 2022
A3 adenosine receptor allosteric modulator CF602 reverses erectile dysfunction in a diabetic rat model.Inbal Itzhak, Shira Cohen, Sari Fishman
|Oct 21, 2021
Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis.Rifaat Safadi, Marius Braun, Adi Francis
|Jun 05, 2018
Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A3 Adenosine Receptor Agonist Piclidenoson.Shira Cohen, Faina Barer, Inbal Itzhak
Pageof 2
